BioCentury
ARTICLE | Regulation

Regulatory reform

July 23, 2001 7:00 AM UTC

Key points in the EC's proposed pharmaceutical reform legislation (see Online Links, A16):

• Requires all "new active substances" to be reviewed by EMEA...